Soung J, et al. J Am Acad Dermatol. 2026;95(4):1109-1112.
Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis
calendar_today
October 10, 2026
domain
protagonist-therapeutics